Diphtheria Trials in Bangkok, Thailand
Conditions / Diphtheria / Bangkok, Thailand
Diphtheria has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02458183 | Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS | COMPLETED | PHASE3 |
| NCT07444502 | Safety Monitoring of Boostagen® Vaccine in Thailand | COMPLETED | — |
| NCT00255021 | Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand | COMPLETED | PHASE4 |
| NCT00317187 | Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. | COMPLETED | PHASE3 |
| NCT00197275 | Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants | COMPLETED | PHASE3 |
| NCT00401531 | Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants | COMPLETED | PHASE3 |
| NCT00228917 | Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children | COMPLETED | PHASE3 |
| NCT00136604 | Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m | COMPLETED | PHASE3 |
| NCT00317161 | Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. | COMPLETED | PHASE3 |
| NCT01031303 | Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age | COMPLETED | PHASE4 |